Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 284

Similar articles for PubMed (Select 18802783)

1.

First renin inhibitor, aliskiren, for the treatment of hypertension.

Triller DM, Evang SD, Tadrous M, Yoo BK.

Pharm World Sci. 2008 Dec;30(6):741-9. doi: 10.1007/s11096-008-9252-1. Epub 2008 Sep 18. Review.

PMID:
18802783
2.

Aliskiren: an oral direct renin inhibitor for the treatment of hypertension.

Sanoski CA.

Pharmacotherapy. 2009 Feb;29(2):193-212. doi: 10.1592/phco.29.2.193. Review.

PMID:
19170589
3.

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.

Am J Hypertens. 2007 Jan;20(1):11-20.

PMID:
17198906
4.

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.

J Hypertens. 2007 Jan;25(1):217-26.

PMID:
17143194
5.

Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.

Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, Maboudian M, Botha J, van Ingen H.

Circulation. 2009 Jan 27;119(3):417-25. doi: 10.1161/CIRCULATIONAHA.107.750745. Epub 2009 Jan 12.

6.

Aliskiren: an oral renin inhibitor for the treatment of hypertension.

Lam S, Choy M.

Cardiol Rev. 2007 Nov-Dec;15(6):316-23. Review.

PMID:
18090068
7.

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.

Andersen K, Weinberger MH, Egan B, Constance CM, Ali MA, Jin J, Keefe DL.

J Hypertens. 2008 Mar;26(3):589-99. doi: 10.1097/HJH.0b013e3282f3ad9a.

PMID:
18300872
9.

Aliskiren: renin inhibitor for hypertension management.

Cheng JW.

Clin Ther. 2008 Jan;30(1):31-47. doi: 10.1016/j.clinthera.2008.01.011. Review.

PMID:
18343241
10.

Blood pressure lowering efficacy of renin inhibitors for primary hypertension: a Cochrane systematic review.

Musini VM, Fortin PM, Bassett K, Wright JM.

J Hum Hypertens. 2009 Aug;23(8):495-502. doi: 10.1038/jhh.2008.162. Epub 2009 Jan 22. Review.

PMID:
19158826
11.

Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.

Dietz R, Dechend R, Yu CM, Bheda M, Ford J, Prescott MF, Keefe DL.

J Renin Angiotensin Aldosterone Syst. 2008 Sep;9(3):163-75. doi: 10.1177/1470320308096411.

PMID:
18957387
12.

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.

Solomon SD, Appelbaum E, Manning WJ, Verma A, Berglund T, Lukashevich V, Cherif Papst C, Smith BA, Dahlöf B; Aliskiren in Left Ventricular Hypertrophy (ALLAY) Trial Investigators.

Circulation. 2009 Feb 3;119(4):530-7. doi: 10.1161/CIRCULATIONAHA.108.826214. Epub 2009 Jan 19.

13.

Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.

O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.

Hypertension. 2007 Feb;49(2):276-84. Epub 2006 Dec 11.

14.

The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.

Gradman AH, Traub D.

Rev Cardiovasc Med. 2007;8 Suppl 2:S22-30. Review.

PMID:
17401313
15.

Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension.

Verdecchia P, Calvo C, Möckel V, Keeling L, Satlin A.

Blood Press. 2007;16(6):381-91.

PMID:
18058456
16.

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension.

Jordan J, Engeli S, Boye SW, Le Breton S, Keefe DL.

Hypertension. 2007 May;49(5):1047-55. Epub 2007 Mar 12.

17.

Aliskiren for renin inhibition: a new class of antihypertensives.

Van Tassell BW, Munger MA.

Ann Pharmacother. 2007 Mar;41(3):456-64. Epub 2007 Mar 6. Review.

PMID:
17341529
18.

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.

Uresin Y, Taylor AA, Kilo C, Tschöpe D, Santonastaso M, Ibram G, Fang H, Satlin A.

J Renin Angiotensin Aldosterone Syst. 2007 Dec;8(4):190-8. doi: 10.3317/jraas.2007.028.

PMID:
18205098
19.

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.

Nussberger J, Gradman AH, Schmieder RE, Lins RL, Chiang Y, Prescott MF.

Int J Clin Pract. 2007 Sep;61(9):1461-8. Epub 2007 Jun 22.

PMID:
17590217
20.

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.

Gradman AH, Schmieder RE, Lins RL, Nussberger J, Chiang Y, Bedigian MP.

Circulation. 2005 Mar 1;111(8):1012-8. Epub 2005 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk